Back to Morgan Stanley Morgan Stanley

TVGNTVGN

Showing 7 of 8 quarters

Position history for Morgan StanleyMorgan Stanley's holdings in TEVOGEN BIO HOLDINGS INC

As of its Q4 2025 13F, Morgan Stanley held 250,258 shares of TVGN (Tevogen Bio Holdings), worth $82,861. Morgan Stanley's 13F filings listed TVGN from Q2 2024 to Q4 2025, 7 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$18,406

Total Shares Change

-49,964

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$4.52
0
2025-Q4
Increased
250,258
+97.6%
$82,8610.0%$16.55
23
2025-Q3
Decreased
126,656
-14.9%
$99,4620.0%$39.25
0
2025-Q2
Increased
148,922
+126.0%
$186,1530.0%$62.50
25
2025-Q1
Decreased
65,901
-16.6%
$71,1720.0%$54.00
0
2024-Q4
Increased
79,032
+58.2%
$81,4030.0%$51.50
21
2024-Q3
Increased
49,964
+141.4%
$18,4060.0%$18.40
20

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used